BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11720163)

  • 1. Central nervous system symptoms in a population of Behçet's disease patients with refractory uveitis treated with cyclosporine A.
    Kato Y; Numaga J; Kato S; Kaburaki T; Kawashima H; Fujino Y
    Clin Exp Ophthalmol; 2001 Oct; 29(5):335-6. PubMed ID: 11720163
    [No Abstract]   [Full Text] [Related]  

  • 2. Central nervous system symptoms in patients with Behçet disease receiving cyclosporine therapy.
    Kotake S; Higashi K; Yoshikawa K; Sasamoto Y; Okamoto T; Matsuda H
    Ophthalmology; 1999 Mar; 106(3):586-9. PubMed ID: 10080218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporine for Behçet's uveitis: is it associated with an increased risk of neurological involvement?
    Akman-Demir G; Ayranci O; Kurtuncu M; Vanli EN; Mutlu M; Tugal-Tutkun I
    Clin Exp Rheumatol; 2008; 26(4 Suppl 50):S84-90. PubMed ID: 19026121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlorambucil and cyclosporine A in Brazilian patients with Behçet's disease uveitis: a retrospective study.
    Zaghetto JM; Yamamoto MM; Souza MB; Silva FT; Hirata CE; Olivalves E; Yamamoto JH
    Arq Bras Oftalmol; 2010; 73(1):40-6. PubMed ID: 20464112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of ultrasound biomicroscopy, indocyanine green angiography and HLA-B51 testing as adjunct methods in the appraisal of Behçet's uveitis.
    Klaeger AJ; Tran VT; Hiroz CA; Morisod L; Herbort CP
    Int Ophthalmol; 2004 Jan; 25(1):57-63. PubMed ID: 15085978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemolytic uraemic syndrome during cyclosporin therapy for Behcet's disease.
    Chatterjee A; D'Souza RJ
    Nephrol Dial Transplant; 1997 Dec; 12(12):2799-800. PubMed ID: 9430907
    [No Abstract]   [Full Text] [Related]  

  • 7. Results of interferon alpha-2a therapy in patients with Behcet's disease.
    Yalçindağ FN; Uzun A
    J Ocul Pharmacol Ther; 2012 Aug; 28(4):439-43. PubMed ID: 22455657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentoxifylline for the treatment of anterior uveitis in Behcet's disease: possible alternative for TNF blockers.
    Appenzeller S; Hazel E
    Rheumatol Int; 2011 Nov; 31(11):1511-3. PubMed ID: 20013266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of IFN-gamma-producing CD56+ T cells after combined low-dose cyclosporine/prednisone treatment in patients with Behçet's uveitis.
    Ahn JK; Seo JM; Yu J; Oh FS; Chung H; Yu HG
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2458-64. PubMed ID: 15980236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracranial hemorrhage in neuro-Behçet's syndrome.
    Kikuchi S; Niino M; Shinpo K; Terae S; Tashiro K
    Intern Med; 2002 Sep; 41(9):692-5. PubMed ID: 12322793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporin-A therapy in severe uveitis of Behçet's disease.
    Süllü Y; Oge I; Erkan D; Aritürk N; Mohajeri F
    Acta Ophthalmol Scand; 1998 Feb; 76(1):96-9. PubMed ID: 9541443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Myalgia in Neuro-Behçet's disease. Medication side effects or expression of underlying disease].
    Krämer M; Baumgärtel MW; Neuen-Jacob E; Berlit P
    Z Rheumatol; 2008 May; 67(3):232-6. PubMed ID: 18365217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of Behçet's disease in Asian countries and Japan.
    Kaneko F; Nakamura K; Sato M; Tojo M; Zheng X; Zhang JZ
    Adv Exp Med Biol; 2003; 528():25-9. PubMed ID: 12918655
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemolytic uremic syndrome/thrombotic thrombocytopenic purpura in a patient with Behçet's disease treated with cyclosporin.
    Docci D; Baldrati L; Capponcini C; Facchini F; Giudicissi A; Feletti C
    Nephron; 1997; 75(3):356-7. PubMed ID: 9069461
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Behçet's disease.
    Whitcup SM; Salvo EC; Nussenblatt RB
    Am J Ophthalmol; 1994 Jul; 118(1):39-45. PubMed ID: 8023874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azathioprine and low dose pulse cyclophosphamide in severe ocular lesions of Behçet's disease. A preliminary report.
    Shahram F; Davatchi F; Chams H; Nadji A; Jamshidi A; Akbarian M; Gharibdoost F
    Adv Exp Med Biol; 2003; 528():571-3. PubMed ID: 12918767
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ciclosporin-associated cerebral tumor-like location of Behçet's disease].
    Bouomrani S; Hammami S; Braham R; Mahjoub S
    Rev Neurol (Paris); 2010 Oct; 166(10):849-54. PubMed ID: 20346476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciclosporin microemulsion preconcentrate treatment of patients with Behçet's disease.
    Fujino Y; Joko S; Masuda K; Yagi I; Kogure M; Sakai J; Usui M; Kotake S; Matsuda H; Ikeda E; Mochizuki M; Nakamura S; Ohno S
    Jpn J Ophthalmol; 1999; 43(4):318-26. PubMed ID: 10482480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of cyclosporine on mucocutaneous manifestations of Behçet's disease.
    Avci O; Gürler N; Güneş AT
    J Am Acad Dermatol; 1997 May; 36(5 Pt 1):796-7. PubMed ID: 9146551
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term therapy with low dose cyclosporin A in ocular Behçet's disease.
    Ozdal PC; Ortaç S; Taskintuna I; Firat E
    Doc Ophthalmol; 2002 Nov; 105(3):301-12. PubMed ID: 12539855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.